Alto Neuroscience Inc (ANRO)
NYSE
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Return on Assets (%) | -108.979 | -52.814 |
Return on Equity (%) | 144.3 | 65.962 |
Return on Invested Capital (%) | -135.026 | -61.529 |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Book Value Per Share | 4.041 | 8.265 |
Earnings Per Share | -3.31 | -4.298 |
Cash Per Share | 5.775 | 9.774 |
Working Capital Per Share | 5.216 | 9.446 |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | -3.31 | -4.298 |
EBITDA Per Share | -3.31 | -4.298 |
Free Cash Flow Per Share | -3.264 | -4.287 |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | 8.853 | 15.221 |
Quick Ratio | 8.755 | 14.714 |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | 8.37M | N/A |
Year End December 30 2023 | Dec 2023 | Mar 2024 |
---|---|---|
USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A |
Return on Assets (%) | N/A | N/A |
Return on Equity (%) | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Sales Per Share | N/A | N/A |
Book Value Per Share | N/A | N/A |
Earnings Per Share | N/A | N/A |
Cash Per Share | N/A | N/A |
Working Capital Per Share | N/A | N/A |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | N/A | N/A |
EBITDA Per Share | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A |
Current Ratio | N/A | 26.019 |
Quick Ratio | N/A | 25.718 |
Inventory Turnover (Days) | N/A | N/A |
Market Cap | 386.05M |
Price to Earnings Ratio | -10.04 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.42 |
Price to Book Ratio | 5.22 |
Dividend Yield | - |
Shares Outstanding | 26.88M |
Average Volume (1 week) | 77.68k |
Average Volume (1 Month) | 127.85k |
52 Week Change | -38.55% |
52 Week High | 24.00 |
52 Week Low | 9.40 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.